ABBOTT-CITALOPRAM TABLET Canada - English - Health Canada

abbott-citalopram tablet

abbott laboratories, limited - citalopram (citalopram hydrobromide) - tablet - 40mg - citalopram (citalopram hydrobromide) 40mg - selective-serotonin reuptake inhibitors

MONOFER iron (as ferric derisomaltose) 1000 mg/10 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

monofer iron (as ferric derisomaltose) 1000 mg/10 ml solution for injection vial

a menarini australia pty ltd - ferric derisomaltose, quantity: 4170 mg (equivalent: iron, qty mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - monofer is indicated for the treatment of iron deficiency in adults, under the following conditions:- when oral iron preparations are ineffective or cannot be used - where there is a clinical need to deliver iron rapidly the diagnosis must be based on laboratory tests.

MONOFER iron (as ferric derisomaltose) 500 mg/5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

monofer iron (as ferric derisomaltose) 500 mg/5 ml solution for injection vial

a menarini australia pty ltd - ferric derisomaltose, quantity: 2085 mg (equivalent: iron, qty mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - monofer is indicated for the treatment of iron deficiency in adults, under the following conditions:- when oral iron preparations are ineffective or cannot be used - where there is a clinical need to deliver iron rapidly the diagnosis must be based on laboratory tests.

MONOFER iron (as ferric derisomaltose) 200 mg/2 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

monofer iron (as ferric derisomaltose) 200 mg/2 ml solution for injection vial

a menarini australia pty ltd - ferric derisomaltose, quantity: 834 mg (equivalent: iron, qty mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - monofer is indicated for the treatment of iron deficiency in adults, under the following conditions:- when oral iron preparations are ineffective or cannot be used - where there is a clinical need to deliver iron rapidly the diagnosis must be based on laboratory tests.

FERINJECT iron (as ferric carboxymaltose) 1000 mg/20 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

ferinject iron (as ferric carboxymaltose) 1000 mg/20 ml injection vial

seqirus pty ltd - ferric carboxymaltose, quantity: 3.6 g (equivalent: iron, qty 1000 mg) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - ferinject is indicated for the treatment of iron deficiency in adults and adolescents aged 14 years and older when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used ? there is a clinical need to deliver iron rapidly,the diagnosis of iron deficiency must be based on laboratory tests.,ferinject is indicated for the treatment of iron deficiency anaemia in children aged 1 to 13 years when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used,the diagnosis of iron deficiency anaemia must be based on laboratory tests.

MONOFER iron (as ferric derisomaltose) 100 mg/1 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

monofer iron (as ferric derisomaltose) 100 mg/1 ml solution for injection vial

a menarini australia pty ltd - ferric derisomaltose, quantity: 417 mg (equivalent: iron, qty mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - monofer is indicated for the treatment of iron deficiency in adults, under the following conditions: - when oral iron preparations are ineffective or cannot be used; - where there is a clinical need to deliver iron rapidly the diagnosis must be based on laboratory tests.

SODIUM FERRIC GLUCONATE COMPLEX- sodium ferric gluconate complex injection United States - English - NLM (National Library of Medicine)

sodium ferric gluconate complex- sodium ferric gluconate complex injection

actavis pharma, inc. - sodium ferric gluconate complex (unii: cc9149u2qx) (ferric cation - unii:91o4lml611) - ferric cation 12.5 mg in 1 ml - sodium ferric gluconate complex in sucrose injection is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. - known hypersensitivity to sodium ferric gluconate or any of its components. pregnancy category b there are no adequate and well-controlled studies with sodium ferric gluconate complex in sucrose injection in pregnant women. reproduction studies have been performed in mice at doses up to 100 mg/kg/day (300 mg/m2 /day) and in rats at up to 20 mg/kg/day (120 mg/m2 /day). the doses in mice and rats are 4 and 1.5 times the human dose of 125 mg/day (77 mg/m2 /day) on a body surface area basis and have revealed no evidence of harm to the fetus due to sodium ferric gluconate complex in sucrose injection. because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly need

SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE- sodium ferric gluconate complex injection United States - English - NLM (National Library of Medicine)

sodium ferric gluconate complex in sucrose- sodium ferric gluconate complex injection

actavis pharma, inc. - sodium ferric gluconate complex (unii: cc9149u2qx) (ferric cation - unii:91o4lml611) - ferric cation 12.5 mg in 1 ml - sodium ferric gluconate complex in sucrose injection is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. - known hypersensitivity to sodium ferric gluconate or any of its components. pregnancy category b there are no adequate and well-controlled studies with sodium ferric gluconate complex in sucrose injection in pregnant women. reproduction studies have been performed in mice at doses up to 100 mg/kg/day (300 mg/m2 /day) and in rats at up to 20 mg/kg/day (120 mg/m2 /day). the doses in mice and rats are 4 and 1.5 times the human dose of 125 mg/day (77 mg/m2 /day) on a body surface area basis and have revealed no evidence of harm to the fetus due to sodium ferric gluconate complex in sucrose injection. because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly ne

IBERET FOLIC 500 FILMTAB Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

iberet folic 500 filmtab

abbott laboratories (m) sdn. bhd. - folic acid; calcium pantothenate; ascorbic acid; riboflavine; niacinamide; ferrous sulfate; thiamine mononitrate; vitamin b12; pyridoxine hcl -

MONOFERRIC SOLUTION Canada - English - Health Canada

monoferric solution

pharmacosmos a/s - iron (ferric derisomaltose) - solution - 100mg - iron (ferric derisomaltose) 100mg - iron preparations